prikaz prve stranice dokumenta Antithrombotics in heart failure
  Download
PDF 134.57 KB
Scientific paper - Review paper
Antithrombotics in heart failure
Croatian Medical Journal, 55 (2014), 6; 621-627. https://doi.org/10.3325/cmj.2014.55.621
Miličić, Davor; Samardžić, Jure; Petričević, Mate

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Miličić, D., Samardžić, J. & Petričević, M. (2014). Antithrombotics in heart failure. Croatian Medical Journal, 55. (6), 621-627. doi: 10.3325/cmj.2014.55.621

Miličić, Davor, et al. "Antithrombotics in heart failure." Croatian Medical Journal, vol. 55, no. 6, 2014, pp. 621-627. https://doi.org/10.3325/cmj.2014.55.621

Miličić, Davor, Jure Samardžić and Mate Petričević. "Antithrombotics in heart failure." Croatian Medical Journal 55, no. 6 (2014): 621-627. https://doi.org/10.3325/cmj.2014.55.621

Miličić, D., Samardžić, J. and Petričević, M. (2014) 'Antithrombotics in heart failure', Croatian Medical Journal, 55(6), pp. 621-627. doi: 10.3325/cmj.2014.55.621

Miličić D, Samardžić J, Petričević M. Antithrombotics in heart failure. Croatian Medical Journal [Internet]. 2014 December [cited 2024 May 07];55(6):621-627. doi: 10.3325/cmj.2014.55.621

D. Miličić, J. Samardžić and M. Petričević, "Antithrombotics in heart failure", Croatian Medical Journal, vol. 55, no. 6, pp. 621-627, December 2014. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:975430. [Accessed: 07 May 2024]

Metadata
Title (english)Antithrombotics in heart failure
AuthorDavor Miličić
AuthorJure Samardžić
AuthorMate Petričević
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Heart failure is a common clinical condition associated with high morbidity and mortality rate despite significant improvements in pharmacotherapy and implementation of medical procedures. Patients with heart failure are at an increased risk of developing arterial and venous thrombosis, which contribute to the high rate of adverse events and fatal outcomes. Many heart failure patients routinely receive antithrombotic therapy due to the presence of a specific indication for its use, like ischemic heart disease or atrial fibrillation. However, there is no solid evidence to support the routine use of antithrombotic agents in all heart failure patients. This article reviews the evidence for using antithrombotic therapy in heart failure patients.
Abstract (croatian)
Antitrombotici u liječenju zatajenja srca ----- Zatajenje srca često je kliničko stanje povezano s visokim pobolom i smrtnošću unatoč brzom razvoju farmakoterapijskih i medicinskih postupaka. Pacijenti sa zatajenjem srca imaju povećan rizik obolijevanja od arterijske i venske tromboze, što doprinosi visokoj stopi neželjenih događaja i smrtnih ishoda. Mnogi bolesnici rutinski se liječe antitromboticima kada postoji specifična indikacija za njihovu uporabu, kao što je ishemijska bolest srca ili fibrilacija atrija. Međutim, ne postoje dokazi koji podupiru rutinsku uporabu antitrombotika kod svih pacijenata sa zatajenjem srca. Ovaj članak vrši pregled dokaza u prilog korištenja antitrombotika kod pacijenata sa zatajenjem srca.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleCroatian Medical Journal
Numberingvol. 55, no. 6, pp. 621-627
p-ISSN0353-9504
DOIhttps://doi.org/10.3325/cmj.2014.55.621
URN:NBNurn:nbn:hr:105:975430
Publication2014-12
Document URLhttps://doi.org/10.3325/cmj.2014.55.621
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 08:26:33